- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2025
- 196 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- November 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- April 2024
- 447 Pages
Global
From €4008EUR$4,200USD£3,358GBP
- Report
- March 2025
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- December 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 93 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 89 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- May 2024
- 124 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- February 2025
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- March 2025
- 179 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- May 2024
- 250 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- May 2024
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 485 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- October 2023
- 385 Pages
Global
From €4724EUR$4,950USD£3,958GBP

Polyclonal antibodies are a type of immune disorder drug used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. These drugs are made up of a mixture of antibodies that are produced by the body in response to a foreign substance, such as a virus or bacteria. They work by targeting and neutralizing the foreign substance, thus preventing it from causing further damage. Polyclonal antibodies can be administered intravenously, intramuscularly, or subcutaneously.
Polyclonal antibodies are used to treat a variety of conditions, including rheumatoid arthritis, multiple sclerosis, Crohn's disease, and psoriasis. They are also used to treat certain types of cancer, such as lymphoma and leukemia. In addition, polyclonal antibodies are used to treat allergies, such as hay fever and asthma.
The polyclonal antibodies market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more